Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levomilnacipran ER in Major Depressive Disorder
NCT00969150Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Sep 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levomilnacipran in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Sep 2009; status: completed.
02
Drugs
levomilnacipran
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00969150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00969150.